NO173998C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater

Info

Publication number
NO173998C
NO173998C NO883229A NO883229A NO173998C NO 173998 C NO173998 C NO 173998C NO 883229 A NO883229 A NO 883229A NO 883229 A NO883229 A NO 883229A NO 173998 C NO173998 C NO 173998C
Authority
NO
Norway
Prior art keywords
therapeutically active
benzimidazole derivatives
analogous procedures
preparing therapeutically
active benzimidazole
Prior art date
Application number
NO883229A
Other languages
English (en)
Norwegian (no)
Other versions
NO883229D0 (no
NO883229L (no
NO173998B (no
Inventor
Tomas Boerje Alminger
Rolf Axel Bergman
Hans Bundgaard
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8604998A external-priority patent/SE8604998D0/xx
Priority claimed from SE8605551A external-priority patent/SE8605551D0/xx
Priority claimed from SE8704049A external-priority patent/SE8704049D0/xx
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO883229D0 publication Critical patent/NO883229D0/no
Publication of NO883229L publication Critical patent/NO883229L/no
Publication of NO173998B publication Critical patent/NO173998B/no
Publication of NO173998C publication Critical patent/NO173998C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO883229A 1986-11-21 1988-07-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater NO173998C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8604998A SE8604998D0 (sv) 1986-11-21 1986-11-21 Novel pharmacological compounds
SE8605551A SE8605551D0 (sv) 1986-12-23 1986-12-23 Novel pharmacological compounds
SE8704049A SE8704049D0 (sv) 1987-10-16 1987-10-16 Novel pharmacological compounds
PCT/SE1987/000546 WO1988003921A1 (fr) 1986-11-21 1987-11-20 Nouveaux derives de benzimidazole, procede de production desdits derives et composition pharmaceutique les contenant

Publications (4)

Publication Number Publication Date
NO883229D0 NO883229D0 (no) 1988-07-20
NO883229L NO883229L (no) 1988-09-16
NO173998B NO173998B (no) 1993-11-22
NO173998C true NO173998C (no) 1994-03-02

Family

ID=27355365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883229A NO173998C (no) 1986-11-21 1988-07-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater

Country Status (24)

Country Link
EP (3) EP0279149B1 (fr)
JP (1) JPH02500744A (fr)
KR (1) KR890700125A (fr)
AT (1) ATE84032T1 (fr)
AU (1) AU612129B2 (fr)
DE (1) DE3783356T2 (fr)
DK (1) DK365488A (fr)
EG (1) EG18379A (fr)
ES (1) ES2052603T3 (fr)
FI (1) FI892454A (fr)
GR (1) GR3007385T3 (fr)
HU (1) HU204814B (fr)
IE (2) IE61178B1 (fr)
IL (1) IL84504A (fr)
IS (1) IS1565B (fr)
LV (1) LV10954B (fr)
MY (1) MY101784A (fr)
NO (1) NO173998C (fr)
NZ (2) NZ222495A (fr)
PL (1) PL157655B1 (fr)
PT (1) PT86186B (fr)
RU (1) RU2062778C1 (fr)
WO (1) WO1988003921A1 (fr)
YU (1) YU47116B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801907D0 (sv) * 1988-05-20 1988-05-20 Haessle Ab Novel pharmacological compounds
US5175286A (en) * 1988-09-20 1992-12-29 Hisamitsu Pharmaceutical Co., Inc. Dibenz[b,e]oxepin derivatives
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
DE69131627T2 (de) * 1990-06-20 2000-04-27 Astra Ab Soedertaelje Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
CA2053527C (fr) * 1990-10-17 2002-03-12 Takashi Sohda Derives de la pyridine, leur production et leur utilisation
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
CA2113561C (fr) * 1992-05-21 1999-09-14 Kazuyoshi Miyata Derive de diester d'acide phosphonique
WO1994026279A1 (fr) * 1993-05-18 1994-11-24 The Upjohn Company Esters de biphosphonate pour traiter les troubles gastriques
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
EP0983263A1 (fr) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
KR20010033811A (ko) * 1997-12-31 2001-04-25 토마스 안 빅토리아 2차 및 3차 아민을 함유하는 약제의 물에 용해가능한프로드럭 및 그것의 제조방법
AU2583901A (en) 1999-12-17 2001-06-25 Ariad Pharmaceuticals, Inc. Proton pump inhibitors
AU2001294228A1 (en) * 2000-10-12 2002-04-22 Takeda Chemical Industries Ltd. Benzimidazole compounds, process for producing the same and use thereof
US20040248941A1 (en) * 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof
ATE467637T1 (de) * 2005-07-28 2010-05-15 Intervet Int Bv Neue benzimidazol(thio)carbamate mit antiparasitischer wirkung und ihre synthese
CA3000985C (fr) 2014-10-14 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Procede pour le traitement de maladies neurodegeneratives
KR20180094989A (ko) 2015-12-15 2018-08-24 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 노화 관련 인지장애 및 신경염증의 예방 및/또는 치료 방법
TW202019410A (zh) 2018-08-06 2020-06-01 小利蘭史丹佛大學董事會 作為用於治療神經退化性疾病的ppargc1a活化劑的2-芳基苯并咪唑
JP7409383B2 (ja) * 2019-08-20 2024-01-09 小野薬品工業株式会社 Ｓ１ｐ５受容体作動活性を有する化合物の塩および結晶形

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (fr) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS5836312B2 (ja) * 1978-08-21 1983-08-08 日本電信電話株式会社 通信用平衡ケ−ブル線路の障害位置測定方式
JPS5687818A (en) * 1979-12-19 1981-07-16 Ishikawajima Harima Heavy Ind Co Ltd Reflex type position detector
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
JPS57137860A (en) * 1981-02-20 1982-08-25 Sumitomo Electric Ind Ltd Optical tachometer
JPS5999597A (ja) * 1982-11-30 1984-06-08 株式会社東芝 光学測定装置
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6020051U (ja) * 1983-07-19 1985-02-12 三洋電機株式会社 カセツト収納装置
AU568441B2 (en) 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds

Also Published As

Publication number Publication date
NO883229D0 (no) 1988-07-20
ES2052603T3 (es) 1994-07-16
LV10954B (en) 1996-08-20
PL157655B1 (pl) 1992-06-30
NO883229L (no) 1988-09-16
IS1565B (is) 1994-12-13
IE873125L (en) 1988-05-21
EP0279149A2 (fr) 1988-08-24
DK365488D0 (da) 1988-07-01
EP0279149B1 (fr) 1992-12-30
IE61178B1 (en) 1994-10-05
NZ234564A (en) 1991-04-26
YU211087A (en) 1988-12-31
PL268927A1 (en) 1989-01-23
DE3783356D1 (de) 1993-02-11
WO1988003921A1 (fr) 1988-06-02
HU204814B (en) 1992-02-28
DK365488A (da) 1988-07-01
EG18379A (en) 1992-11-30
DE3783356T2 (de) 1993-04-15
IS3284A7 (is) 1988-05-22
FI892454A0 (fi) 1989-05-19
AU612129B2 (en) 1991-07-04
RU2062778C1 (ru) 1996-06-27
LV10954A (lv) 1995-12-20
KR890700125A (ko) 1989-03-02
NZ222495A (en) 1991-04-26
EP0279149A3 (en) 1988-08-31
IE940326L (en) 1988-05-21
MY101784A (en) 1992-01-17
JPH02500744A (ja) 1990-03-15
GR3007385T3 (fr) 1993-07-30
HUT51269A (en) 1990-04-28
EP0332647A1 (fr) 1989-09-20
YU47116B (sh) 1994-12-28
PT86186B (pt) 1990-08-31
FI892454A (fi) 1989-05-19
ATE84032T1 (de) 1993-01-15
IL84504A (en) 1994-10-07
NO173998B (no) 1993-11-22
PT86186A (en) 1987-12-01
AU8330287A (en) 1988-06-16
EP0510719A1 (fr) 1992-10-28

Similar Documents

Publication Publication Date Title
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
MY101791A (en) New benzimidazole derivatives
SE8300736D0 (sv) Novel pharmacologically active compounds
SE8804629D0 (sv) New therapeutically active compounds
SE8600658D0 (sv) Novel composition of matter
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
SE8704049D0 (sv) Novel pharmacological compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)